Skip to main content
. 2016 Dec 20;20(5):381–384. doi: 10.5114/wo.2016.64597

Table 2.

The relationship between chemotherapy related AE’s and BRCA1 mutation status

Parameter BRCA1(+) BRCA (–) p
Haematological AE’s
 Any grade
 Grade 3–4

12 (57%)
6 (28.5%)

29 (38.7%)
7 (9.3%)

0.13
0.02
Neuropathy
 Any grade
 Grade 3–4

9 (42.9%)
1 (4.8%)

29 (38.7%)
4 (5.3%)

0.73
0.92
Nausea/vomiting
 Any grade
 Grade 3–4

7 (33.3%)
0

26 (34.7%)
2 (2.7%)

0.94
0.91